Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1940-6207.capr-23-0111
PubMed Identifier: 37756582
Publication URI: http://europepmc.org/abstract/MED/37756582
Type: Journal Article/Review
Volume: 16
Parent Publication: Cancer prevention research (Philadelphia, Pa.)
Issue: 11
ISSN: 1940-6215